title: Cholesterol-lowering blockbuster candidates speed into Phase III trials.
authors.forename: Asher
authors.initials: A
authors.lastname: Mullard
mesh_terms: D000924:Anticholesteremic Agents / Q000494:pharmacology*; D008078:Cholesterol, LDL / Q000097:blood; D017326:Clinical Trials, Phase III as Topic; D015195:Drug Design; D004345:Drug Industry; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases / Q000037:antagonists & inhibitors*; D012697:Serine Endopeptidases
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D012697:Serine Endopeptidases